Literature DB >> 6103451

Time of fertilisation and sex of infants.

W H James.   

Abstract

The sex of a human zygote may depend on the time during the mother's menstrual cycle that it is formed. Direct data to support this hypothesis suggest that male zygotes tend to be formed both early and late in the fertile period, and female zygotes in the middle. Criticisms of the direct data seem to be only that measurements of the timing of events around conception are inexact. There are several kinds of indirect data: (1) the variation of sex ratio with war and with duration of marriage, and (2) the non-binomial distribution of the combination of the sexes in human dizygotic twins and other mammalian polyzygotic litters. The sex of a zygote may be determined by maternal gonadotrophin levels when it is formed. This elaboration of the hypothesis could explain the low sex ratio in Negroes.

Entities:  

Mesh:

Year:  1980        PMID: 6103451     DOI: 10.1016/s0140-6736(80)91565-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  The influence of migration on secular trends in sex ratios at birth in cuba in the past fifty years.

Authors:  V Grech
Journal:  West Indian Med J       Date:  2014-05-05       Impact factor: 0.171

2.  A possible mechanism underlying the sex selectivity of neural tube defect.

Authors:  W H James
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

3.  Gonadotrophin and the human secondary sex ratio.

Authors:  W H James
Journal:  Br Med J       Date:  1980-09-13

4.  Microbial and metabolic profile of achlorhydric stomach: comparison of pernicious anaemia and hypogammaglobulinaemia.

Authors:  S P Borriello; P J Reed; J M Dolby; F E Barclay; A D Webster
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

5.  Paternal effects on the human sex ratio at birth: evidence from interracial crosses.

Authors:  M J Khoury; J D Erickson; L M James
Journal:  Am J Hum Genet       Date:  1984-09       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.